GLP1R and diabetes mellitus: Taking these assumptions into account, the combination of metformin and SGLT-2 inhibitor or GLP-1 receptor agonist (the more beneficial agent remains to be revealed in future) would be the most appropriate treatment among antidiabetic drugs, regarding arterial ageing in patients with diabetes.